logo

Senseonics Holdings, Inc. (SENS)



Trade SENS now with
  Date
  Headline
6/16/2022 6:36:03 AM Senseonics Announces CE Mark Approval Of The Eversense E3 Continuous Glucose Monitoring System
2/11/2022 7:07:53 AM Senseonics Announces FDA Approval Of Eversense E3 Continuous Glucose Monitoring System For Use For Up To 6 Months
6/28/2021 8:23:40 AM Senseonics Announces Presentation Of PROMISE Data At The American Diabetes Association 81st Scientific Sessions
1/28/2021 11:44:05 PM Senseonics Holdings Announces Closing Of $115 Mln Bought Deal Offering Of Common Stock
1/22/2021 12:26:49 AM Senseonics Holdings Increases Bought Deal Offering Of Common Stock To $100.0 Mln
1/17/2021 11:40:40 PM Senseonics Holdings Announces Registered Direct Offering Of 40 Mln Shares At $1.25/Shr